Sanofi - American Depositary Shares · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $15,001 to $50,000
NYSE EURONEXT - EURONEXT PARIS · SNY
+1.50% · +$0.6786 · Vol 1.9M
Market closed · last close 4:00 PM ET · price as of 19:23:34 ET
Sanofi SA
Pharmaceuticals
$45.83
Veridion Score
Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for SNY until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
SovereignWhy is SNY moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Sanofi SA
PharmaceuticalsListed since
2002
Employees
75K
Country
FR
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$45.26
Day high
$46.11
Day low
$45.25
Previous close
$45.15
52W high
$52.34
-12.44% from high
52W low
$41.33
41% of range
Market cap
$108.2B
P/E
16.24×
EPS
$4.60
Beta
0.11
Shares out
2.4B
Volume
1.9M
0.60× rel vol
Avg volume
3.1M
VWAP
$45.89
Price history computed in-house
1W
+4.82%
1M
+5.69%
3M
+3.47%
1Y
-10.75%
YTD
-5.43%
SMA 50 $43.49 · above
SMA 200 $46.03 · below
52W position 41%
SNY overview
Related filings and maps
Public disclosures
Congress activity in SNY
Official filing ↗
Lisa McclainSell
SNY · Transaction Sep 11, 2025 · Filed Oct 22, 2025 · $1,001 to $15,000
Lisa McclainBuy
SNY · Transaction Aug 4, 2025 · Filed Sep 12, 2025 · $1,001 to $15,000
Lisa McclainSell
SNY · Transaction Jul 22, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
Lisa McclainBuy
SNY · Transaction Jun 17, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
Federal contracts
SNY contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SNY in this window.
Lobbying spend
SNY lobbying filings, year to date.
Registered lobbying filings matched to Sanofi SA.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SNY in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for SNY.
Options
Sovereign unlock shows live options positioning for SNY.